Clinical Trial Update: Part A: Drug Interaction Study of Sofosbuvir and Antiretroviral Therapy (ART) Combinations in HIV and Hepatitis C Virus (HCV) Co-infected Patients. Part B: Efficacy and Safety of Sofosbuvir for 12 Weeks in HIV/HCV Co-infected Patients. [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update reports Part A on drug interaction between sofosbuvir and antiretroviral therapy in HIV/HCV co-infected patients, and Part B assessin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection
• Hepatitis C

Drugs mentioned

• Sofosbuvir (sofosbuvir)

Snippet

Sponsor: Gilead Sciences | Conditions: Hepatitis C, HIV | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2014-10-01